HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Therapy of bronchial carcinoma from the radiotherapist's viewpoint].

Abstract
The irradiation of radical resectable lung cancer is unambiguously not as effectively as surgery, and also the preoperative radiation with high tumour doses has not demonstrated any benefit in survival rates. Tumours of the superior sulcus could be an exception in both treatment modalities. As shown in randomized studies one could suggest some advantage employing postoperative irradiation of patients especially with mediastinal node metastases. The addition of chemotherapy to high dose irradiation with curative intent in inoperable non-small cell lung cancer has not been shown to increase survival. The combined chemo-radiotherapy of small cell lung cancer significantly reduced the incidence of relapse and prolonged the disease free interval but did not affect long-term survival.
AuthorsA Hackl
JournalOnkologie (Onkologie) Vol. 7 Issue 5 Pg. 268-71 (Oct 1984) ISSN: 0378-584X [Print] Switzerland
Vernacular TitleDie Therapie des Bronchuskarzinoms aus der Sicht des Strahlentherapeuten.
PMID6096781 (Publication Type: English Abstract, Journal Article)
Topics
  • Carcinoma, Bronchogenic (radiotherapy, surgery)
  • Carcinoma, Small Cell (radiotherapy)
  • Combined Modality Therapy
  • Humans
  • Lung Neoplasms (radiotherapy, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: